KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

NovoCure (NVCR) Return on Assets (2016 - 2025)

Historic Return on Assets for NovoCure (NVCR) over the last 11 years, with Q3 2025 value amounting to 0.14%.

  • NovoCure's Return on Assets fell 100.0% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.14% for FY2024, which is 400.0% up from last year.
  • Per NovoCure's latest filing, its Return on Assets stood at 0.14% for Q3 2025, which was down 100.0% from 0.14% recorded in Q2 2025.
  • NovoCure's 5-year Return on Assets high stood at 0.01% for Q1 2021, and its period low was 0.18% during Q4 2023.
  • Moreover, its 5-year median value for Return on Assets was 0.12% (2024), whereas its average is 0.1%.
  • Its Return on Assets has fluctuated over the past 5 years, first plummeted by -1000bps in 2023, then skyrocketed by 500bps in 2024.
  • Quarter analysis of 5 years shows NovoCure's Return on Assets stood at 0.05% in 2021, then tumbled by -51bps to 0.08% in 2022, then tumbled by -131bps to 0.18% in 2023, then rose by 24bps to 0.14% in 2024, then grew by 0bps to 0.14% in 2025.
  • Its Return on Assets stands at 0.14% for Q3 2025, versus 0.14% for Q2 2025 and 0.13% for Q1 2025.